Trademark Search in Canada

AMPLIFY

View On IC.GC.CA

REGISTERED

on 8 Mar 2023

Last Applicant/ Owned by

DECIBEL THERAPEUTICS INC.

1325 Boylston Street, Suite 500Boston MA 02215

Serial Number

2126776 filed on 15^th Jun 2021

Registration Number

TMA1170348 registered on 8^th Mar 2023

Registration expiry Date

15^th Jun 2031

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

AMPLIFY

Trademark usage description

genetic testing for medical purposes for the testing of hearing loss and balance disorders; none of the foregoing relating to cancer, auto-immune cond Read More

Classification Information

Class [044]
Genetic testing for medical purposes for the testing of hearing loss and balance disorders; none of the foregoing relating to cancer, auto-immune conditions, infectious diseases, or the immune repertoire.

Classification kind code

Mark Details

Serial Number

2126776

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 222 on 19^th Dec 2022	Opposition Start Date Notice Sent
Submitted for opposition 26 on 28^th Nov 2022	Approved
Submitted for opposition 27 on 28^th Nov 2022	Approval Notice Sent
Submitted for opposition 22 on 22^nd Nov 2022	Search Recorded
Submitted for opposition 256 on 13^th Jun 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 12^th Aug 2021	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 11^th Aug 2021	Created
Submitted for opposition 31 on 11^th Aug 2021	Formalized
Submitted for opposition 30 on 15^th Jun 2021	Filed
Submitted for opposition 228 on 15^th Jun 2021	International Registration

AMPLIFY

Classification Information

Class [044]Genetic testing for medical purposes for the testing of hearing loss and balance disorders; none of the foregoing relating to cancer, auto-immune conditions, infectious diseases, or the immune repertoire.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [044]
Genetic testing for medical purposes for the testing of hearing loss and balance disorders; none of the foregoing relating to cancer, auto-immune conditions, infectious diseases, or the immune repertoire.